Drug results: 22
aluminium chlorohydrate | antiperspirant; structure | |
aluminium chloride | A compound with the chemical formula AlCl3; the anhydrous salt is used as a catalyst in organic chemical synthesis, and hydrated salts are used topically as antiperspirants, and for the management of HYPERHYDROSIS. | |
aluminum acetate | astringent for temporary relief of minor skin irritations | |
aluminium clofibrate | ||
aluminium nicotinate | ||
aluminium acetoacetate | ||
aluminium phosphate | gel used as immunologic adjuvent; RN given refers to Al salt | |
aluminium oxide | ||
aluminium acetotartrate | ||
aluminium glycinate | ||
algeldrate | A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc. | |
aminocaproic acid | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | |
calcium carbonate | Carbonic acid calcium salt (CaCO3). An odorless, tasteless powder or crystal that occurs in nature. It is used therapeutically as a phosphate buffer in hemodialysis patients and as a calcium supplement. | |
sodium monofluorophosphate | inhibits Phosphorylas phosphatase irreversibly; RN given refers to parent cpd | |
silicon dioxide | A non-crystalline form of silicon oxide that has absorptive properties. It is commonly used as a desiccating agent and as a stationary phase for CHROMATOGRAPHY. The fully hydrated form of silica gel has distinct properties and is referred to as SILICIC ACID. | |
calcium hydrogen phosphate dihydrate | ||
allantoin | A urea hydantoin that is found in URINE and PLANTS and is used in dermatological preparations. | |
magaldrate | composed of aluminium and magnesium hydroxides and sulphates, used as an antacid | |
carbaldrate | ||
aloglutamol | ||
deferasirox | A triazole and benzoate derivative that acts as a selective iron chelator. It is used in the management of chronic IRON OVERLOAD due to blood transfusion or non-transfusion dependent THALASSEMIA. | |
acipimox | lipolysis inhibitor |
Citing DrugCentral © 2024. License